152
Views
85
CrossRef citations to date
0
Altmetric
Original Research

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life

, , , , , , , , & show all
Pages 39-46 | Published online: 20 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Yodpong Chantarasorn, Kochapong Rasmidatta, Itsara Pokawattana & Sukhum Silpa-archa. (2022) Effects of Ketoconazole on the Clinical Recovery in Central Serous Chorioretinopathy. Clinical Ophthalmology 16, pages 1871-1882.
Read now
Danial Mohabati, Camiel J F Boon & Suzanne Yzer. (2020) Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy. Clinical Ophthalmology 14, pages 1165-1175.
Read now
Danial Mohabati, Elon HC van Dijk, Thomas J van Rijssen, Eiko K de Jong, Myrte B Breukink, Jose P Martinez-Ciriano, Greet Dijkman, Carel B Hoyng, Sascha Fauser, Suzanne Yzer & Camiel JF Boon. (2018) Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy. Clinical Ophthalmology 12, pages 2167-2176.
Read now
Juliane Maria Doepfner, Stephan Michels, Nicole Graf, Matthias Dieter Becker & Florentina Joyce Freiberg. (2018) Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study. Clinical Ophthalmology 12, pages 1301-1309.
Read now
Danial Mohabati, Thomas J van Rijssen, Elon HC van Dijk, Gregorius PM Luyten, Tom O Missotten, Carel B Hoyng, Suzanne Yzer & Camiel JF Boon. (2018) Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy. Clinical Ophthalmology 12, pages 1061-1070.
Read now
Chen‐wei Pan, Rong‐kun Wu, Pei Wang, Jun Li & Hua Zhong. (2018) Reduced vision, refractive errors and health‐related quality of life among adolescents in rural China. Clinical and Experimental Optometry 101:6, pages 758-763.
Read now

Articles from other publishers (79)

Filippos Vingopoulos, Itika Garg, Esther Lee Kim, Merina Thomas, Rebecca F Silverman, Megan Kasetty, Zakariyya Y Hassan, Gina Yu, Katherine Joltikov, Eun Young Choi, Inês Laíns, Leo A Kim, David N Zacks & John B Miller. (2023) Quantitative contrast sensitivity test to assess visual function in central serous chorioretinopathy. British Journal of Ophthalmology 107:8, pages 1139-1143.
Crossref
Haidong Li, Lifeng Chen, Meng'ai Wu & Bin Zheng. (2023) Analysis of retinal sensitivity between acute and recurrent central serous chorioretinopathy by microperimetry. Photodiagnosis and Photodynamic Therapy 42, pages 103576.
Crossref
Carlos Oribio-Quinto, José Ignacio Fernández-Vigo, Valentina Bilbao-Malavé, Pilar Pérez-García, Barbara Burgos-Blasco, Luis Arias-Barquet & Juan Donate-López. (2023) Anatomical and functional impact of verteporfin shortage in patients with chronic central serous chorioretinopathy. Photodiagnosis and Photodynamic Therapy 42, pages 103501.
Crossref
Danial Mohabati, Camiel J. F. Boon, Carel B. Hoyng, Konstantine Purtskhvanidze, Johann Roider & Elon H. C. van Dijk. (2023) Fundus autofluorescence abnormalities can predict fluorescein angiography abnormalities in patients with chronic central serous chorioretinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology.
Crossref
Adrian T. Fung, Yi Yang & Andrew W. Kam. (2023) Central serous chorioretinopathy: A review. Clinical & Experimental Ophthalmology 51:3, pages 243-270.
Crossref
Maciej Gawęcki, Andrzej Grzybowski & Anna Święch. (2023) Biometric Risk Factors for Central Serous Chorioretinopathy. Ophthalmology and Therapy 12:2, pages 1327-1338.
Crossref
Yousif Subhi, Josefine Windfeld-Mathiasen, Anna Horwitz & Henrik Horwitz. (2023) Risk of Central Serous Chorioretinopathy in Male Androgen Abusers. Ophthalmology and Therapy 12:2, pages 1073-1080.
Crossref
Elon H. C. van Dijk, Helena M. A. Feenstra, Jakob Bjerager, Jakob Grauslund, Camiel J. F. Boon & Yousif Subhi. (2022) Comparative efficacy of treatments for chronic central serous chorioretinopathy: A systematic review with network meta‐analyses . Acta Ophthalmologica 101:2, pages 140-159.
Crossref
Helena M. A. Feenstra, Roselie M. H. Diederen, Martine J. C. M. Lamme, Roula Tsonaka, Sascha Fauser, Suzanne Yzer, Thomas van Rijssen, Theodora Gkika, Susan M. Downes, Reinier O. Schlingemann, Carel B. Hoyng, Elon H. C. van Dijk & Camiel J. F. Boon. (2023) INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina 43:3, pages 379-388.
Crossref
Helena M. A. Feenstra, Elon H. C. van Dijk, Thomas J. van Rijssen, Roula Tsonaka, Roselie M. H. Diederen, Carel B. Hoyng, Reinier O. Schlingemann & Camiel J. F. Boon. (2022) Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3. Graefe's Archive for Clinical and Experimental Ophthalmology 261:3, pages 659-668.
Crossref
Maciej Gawęcki & Andrzej Grzybowski. (2022) Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy. Ophthalmology and Therapy 12:1, pages 517-533.
Crossref
Ying Huang, Weiwei Zheng, Zuhua Sun, Shenghai Huang & Bing Lin. (2023) Optical coherence tomography biomarkers as predictors of transition to chronic central serous chorioretinopathy after retinal laser photocoagulation. Therapeutic Advances in Chronic Disease 14, pages 204062232211467.
Crossref
Mario Gutiérrez Paz, Hector Quintanilla & Carlos Estrada-Reyes. (2022) Coriorretinopatía Serosa Central (CRSC). Highlights of Vitreoretina 15:4, pages 12-21.
Crossref
Camila Q. Felipe, Ana Luiza Biancardi, Vinicius T. Civile, Nelson Carvas Junior, Pedro D. Serracarbassa & Marcia K. Koike. (2022) Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analyses. International Journal of Retina and Vitreous 8:1.
Crossref
Helena M.A. Feenstra, Elon H.C. van Dijk, Thomas J. van Rijssen, Roula Tsonaka, Roselie M.H. Diederen, Reinier O. Schlingemann, Carel B. Hoyng & Camiel J.F. Boon. (2022) Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients. Ophthalmology Retina 6:10, pages 930-938.
Crossref
Francesca Amoroso, Alexandre Pedinielli, Salomon Yves Cohen, Camille Jung, Jay Chhablani, Polina Astroz, Donato Colantuono, Oudy Semoun, Vittorio Capuano, Eric H. Souied & Alexandra Miere. (2021) Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response. European Journal of Ophthalmology 32:5, pages 2810-2818.
Crossref
Helena M.A. Feenstra, Jonathan Hensman, Theodora Gkika, Veronika Lipkova, Carel B. Hoyng, Roselie M.H. Diederen, Reinier O. Schlingemann, Susan M. Downes, Elon H.C. van Dijk & Camiel J.F. Boon. (2022) Spontaneous Resolution of Chronic Central Serous Chorioretinopathy: “Fuji Sign”. Ophthalmology Retina 6:9, pages 861-863.
Crossref
Sumit Randhir Singh, Claudio Iovino, Dinah Zur, Dua Masarwa, Matias Iglicki, Ramkailash Gujar, Marco Lupidi, Dmitrii S Maltsev, Elodie Bousquet, Mehdi Bencheqroun, Francesca Amoroso, Luiz H Lima, Srikanta Kumar Padhy, Vishal Govindahari, Khushboo Chandra, Eric H Souied, Francisco J Rodriguez, Laura A Daza, Hernan A Rios, Carlo Cagini, Enrico Peiretti, Francine Behar-Cohen & Jay Chhablani. (2022) Central serous chorioretinopathy imaging biomarkers. British Journal of Ophthalmology 106:4, pages 553-558.
Crossref
Helena M. A. Feenstra, Leo C. Hahn, Thomas J. van Rijssen, Roula Tsonaka, Myrte B. Breukink, Jan. E. E. Keunen, Petrus J. H. Peters, Greet Dijkman, Eric H. Souied, Robert E. MacLaren, Giuseppe Querques, Susan M. Downes, Sascha Fauser, Carel B. Hoyng, Elon H. C. van Dijk & Camiel J. F. Boon. (2022) EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina 42:4, pages 721-729.
Crossref
Claudio Iovino, Enrico Peiretti, Filippo Tatti, Giuseppe Querques, Enrico Borrelli, Riccardo Sacconi, Jay Chhablani, Hitesh Agrawal, Camiel J. F. Boon, Elon H. C. van Dijk, Gilda Cennamo, Marco Lupidi, Alessio Muzi, Valentina Di Iorio, Matias Iglicki, Lital Smadar, Anat Loewenstein & Dinah Zur. (2021) Photodynamic therapy as a treatment option for peripapillary pachychoroid syndrome: a pilot study. Eye 36:4, pages 716-723.
Crossref
Ahmed M. Hagag, Rajna Rasheed, Shruti Chandra, Glen Jeffery & Sobha Sivaprasad. (2022) The Diagnostic Accuracy of Double-Layer Sign in Detection of Macular Neovascularization Secondary to Central Serous Chorioretinopathy. American Journal of Ophthalmology 236, pages 271-280.
Crossref
J. Brinks, E.H.C. van Dijk, I. Klaassen, R.O. Schlingemann, S.M. Kielbasa, E. Emri, P.H.A. Quax, A.A. Bergen, O.C. Meijer & C.J.F. Boon. (2022) Exploring the choroidal vascular labyrinth and its molecular and structural roles in health and disease. Progress in Retinal and Eye Research 87, pages 100994.
Crossref
Junseo Ko, Jinyoung Han, Jeewoo Yoon, Ji In Park, Joon Seo Hwang, Jeong Mo Han, Kyu Hyung Park & Daniel Duck-Jin Hwang. (2022) Assessing central serous chorioretinopathy with deep learning and multiple optical coherence tomography images. Scientific Reports 12:1.
Crossref
Yousif Subhi, Jakob Bjerager, Camiel J.F. Boon & Elon H.C. van Dijk. (2021) Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data. Acta Ophthalmologica 100:1, pages 89-95.
Crossref
Joost Brinks, Elon H C van Dijk, Szymon M Kiełbasa, Hailiang Mei, Isa van der Veen, Hendrika A B Peters, Hetty C M Sips, Robbert G E Notenboom, Paul H A Quax, Camiel J F Boon & Onno C Meijer. (2022) The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy. The Journal of Clinical Endocrinology & Metabolism 107:2, pages 512-524.
Crossref
Jeewoo Yoon, Jinyoung Han, Junseo Ko, Seong Choi, Ji In Park, Joon Seo Hwang, Jeong Mo Han, Kyuhwan Jang, Joonhong Sohn, Kyu Hyung Park & Daniel Duck-Jin Hwang. (2022) Classifying central serous chorioretinopathy subtypes with a deep neural network using optical coherence tomography images: a cross-sectional study. Scientific Reports 12:1.
Crossref
M.M. Bikbov, A.V. Gizzatov & R.M. Zainullin. (2022) Effects of systemic drugs on the development of drug-induced retinopathy. Vestnik oftal'mologii 138:2, pages 94.
Crossref
Thomas J. van Rijssen, Elon H.C. van Dijk, Roula Tsonaka, Helena M.A. Feenstra, Greet Dijkman, Petrus J.H. Peters, Roselie M.H. Diederen, Carel B. Hoyng, Reinier O. Schlingemann & Camiel J.F. Boon. (2022) Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial. American Journal of Ophthalmology 233, pages 101-110.
Crossref
Benedikt Schworm, Nikolaus Luft, Leonie F. Keidel, Thomas C. Kreutzer, Tina R. Herold, Siegfried G. Priglinger & Jakob Siedlecki. (2021) Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy. BMC Ophthalmology 21:1.
Crossref
Shun Kumashiro, Seiji Takagi, Takashi Itokawa, Akiko Tajima, Tatsuhiko Kobayashi & Yuichi Hori. (2021) Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy. BMC Ophthalmology 21:1.
Crossref
Thomas J. Rijssen, Elon H. C. Dijk, Paula Scholz, Myrte B. Breukink, Greet Dijkman, Petrus J. H. Peters, Roula Tsonaka, Jan E. E. Keunen, Robert E. MacLaren, Carel B. Hoyng, Susan M. Downes, Sascha Fauser & Camiel J. F. Boon. (2021) Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser. Acta Ophthalmologica 99:7, pages 805-811.
Crossref
Faisal Iqbal, Kashif Iqbal, Bilal Inayat, Sabeen Arjumand, Zarish Ghafoor, Werdah Sattar & Kiran Abbas. (2021) Eplerenone Treatment in Chronic Central Serous Chorioretinopathy. Cureus.
Crossref
Elon H.C. van Dijk & Camiel J.F. Boon. (2021) Serous business: Delineating the broad spectrum of diseases with subretinal fluid in the macula. Progress in Retinal and Eye Research 84, pages 100955.
Crossref
Cong Li, Fabao Xu, Lijun Zhou, Hongkun Zhao, Minzhong Yu, Shaobo Zhou & Chenjin Jin. (2021) Quantitative evaluation of photoreceptor density in chronic central serous chorioretinopathy using the Spectralis High Magnification Module. Photodiagnosis and Photodynamic Therapy 35, pages 102410.
Crossref
Meltem Guzin Altınel, Banu Acikalin, Hasan Gunes & Gokhan Demir. (2021) Optical coherence tomography parameters as predictors of treatment response to a 577-nm subthreshold micropulse laser in chronic central serous chorioretinopathy. Lasers in Medical Science 36:7, pages 1505-1514.
Crossref
Arkadiusz Hoffmann, Paulina Kleniewska & Rafał Pawliczak. (2021) Antioxidative activity of probiotics. Archives of Medical Science 17:3, pages 792-804.
Crossref
Thomas J. van Rijssen, Elon H. C. van Dijk, Paula Scholz, Robert E. MacLaren, Sascha Fauser, Susan M. Downes, Carel B. Hoyng & Camiel J. F. Boon. (2020) Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy. Graefe's Archive for Clinical and Experimental Ophthalmology 259:4, pages 905-910.
Crossref
Stefano Da Pozzo, Pierluigi Iacono, Alessandro Arrigo & Maurizio Battaglia Parodi. (2021) The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy. Pharmaceuticals 14:2, pages 105.
Crossref
Yu Wakatsuki, Koji Tanaka, Ryusaburo Mori, Koichi Furuya, Akiyuki Kawamura & Hiroyuki Nakashizuka. (2021) Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy. Pharmaceuticals 14:1, pages 53.
Crossref
Nilesh Kumar, Nikulaa Parachuri & Ashish Sharma. (2021) Commentary: Acute central serous chorioretinopathy – Treat early, observe longer. Indian Journal of Ophthalmology 69:9, pages 2347.
Crossref
Syed Ale Hassan, Shahzad Akbar, Amjad Rehman, Tanzila Saba, Hoshang Kolivand & Saeed Ali Bahaj. (2021) Recent Developments in Detection of Central Serous Retinopathy Through Imaging and Artificial Intelligence Techniques–A Review. IEEE Access 9, pages 168731-168748.
Crossref
Meenakshi Kumar, Elon H. C. van Dijk, Rajiv Raman, Pooja Mehta, Camiel J. F. Boon, Abhilash Goud, Seelam Bharani & Jay Chhablani. (2020) Stress and vision-related quality of life in acute and chronic central serous chorioretinopathy. BMC Ophthalmology 20:1.
Crossref
Jeewoo Yoon, Jinyoung Han, Ji In Park, Joon Seo Hwang, Jeong Mo Han, Joonhong Sohn, Kyu Hyung Park & Daniel Duck-Jin Hwang. (2020) Optical coherence tomography-based deep-learning model for detecting central serous chorioretinopathy. Scientific Reports 10:1.
Crossref
Rebecca Kaye, Shruti Chandra, Jay Sheth, Camiel J.F. Boon, Sobha Sivaprasad & Andrew Lotery. (2020) Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities. Progress in Retinal and Eye Research 79, pages 100865.
Crossref
Maciej Gawęcki, Agnieszka Jaszczuk & Andrzej Grzybowski. (2020) Short Term Presence of Subretinal Fluid in Central Serous Chorioretinopathy Affects Retinal Thickness and Function. Journal of Clinical Medicine 9:11, pages 3429.
Crossref
Danial Mohabati, Carel B. Hoyng, Suzanne Yzer & Camiel J. F. Boon. (2020) CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY. Retina 40:9, pages 1742-1750.
Crossref
Danial Mohabati, Rosa L. Schellevis, Elon H. C. van Dijk, Sascha Fauser, Anneke I. den Hollander, Carel B. Hoyng, Eiko K. De Jong, Suzanne Yzer & Camiel J. F. Boon. (2020) GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY. Retina 40:9, pages 1734-1741.
Crossref
Thomas J. van Rijssen, Elon H.C. van Dijk, Paula Scholz, Myrte B. Breukink, Greet Dijkman, Petrus J.H. Peters, Roula Tsonaka, Robert E. MacLaren, Susan M. Downes, Sascha Fauser, Camiel J.F. Boon & Carel B. Hoyng. (2020) Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial. American Journal of Ophthalmology 216, pages 80-89.
Crossref
Femke M. Haalen, Elon H. C. Dijk, Mesut Savas, Joost Brinks, Olaf M. Dekkers, Greet Dijkman, Elisabeth F. C. Rossum, Nienke R. Biermasz, Camiel J. F. Boon & Alberto M. Pereira. (2019) Hair cortisol concentrations in chronic central serous chorioretinopathy. Acta Ophthalmologica 98:4, pages 390-395.
Crossref
Martin Stattin, Stefan Hagen, Daniel Ahmed, Eva Smretschnig, Florian Frommlet, Katharina Krepler & Siamak Ansari-Shahrezaei. (2020) Long-Term Effect of Half-Fluence Photodynamic Therapy on Fundus Autofluorescence in Acute Central Serous Chorioretinopathy. Journal of Ophthalmology 2020, pages 1-7.
Crossref
Yoshikatsu Hosoda, Masahiro Miyake, Rosa L. Schellevis, Camiel J. F. Boon, Carel B. Hoyng, Akiko Miki, Akira Meguro, Yoichi Sakurada, Seigo Yoneyama, Yukari Takasago, Masayuki Hata, Yuki Muraoka, Hideo Nakanishi, Akio Oishi, Sotaro Ooto, Hiroshi Tamura, Akihito Uji, Manabu Miyata, Ayako Takahashi, Naoko Ueda-Arakawa, Atsushi Tajima, Takehiro Sato, Nobuhisa Mizuki, Chieko Shiragami, Tomohiro Iida, Chiea Chuen Khor, Tien Yin Wong, Ryo Yamada, Shigeru Honda, Eiko K. de Jong, Anneke I. den Hollander, Fumihiko Matsuda, Kenji Yamashiro & Akitaka Tsujikawa. (2019) Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy. Communications Biology 2:1.
Crossref
Hamid-Reza Moein, Lauren W. Bierman, Eduardo A. Novais, Carlos Moreira-Neto, Caroline R. Baumal, Adam Rogers, Jay S. Duker & André J. Witkin. (2019) Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study. International Journal of Retina and Vitreous 5:1.
Crossref
Maciej Gawęcki, Agnieszka Jaszczuk-Maciejewska, Anna Jurska-Jaśko, Małgorzata Kneba & Andrzej Grzybowski. (2019) Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy. BMC Ophthalmology 19:1.
Crossref
Danial Mohabati, Rosa L. Schellevis, Elon H. C. van Dijk, Lebriz Altay, Sascha Fauser, Carel B. Hoyng, Eiko K. De Jong, Camiel J. F. Boon & Suzanne Yzer. (2019) GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY. Retina 39:12, pages 2303-2310.
Crossref
Thomas J. van Rijssen, Elon H.C. van Dijk, Suzanne Yzer, Kyoko Ohno-Matsui, Jan E.E. Keunen, Reinier O. Schlingemann, Sobha Sivaprasad, Giuseppe Querques, Susan M. Downes, Sascha Fauser, Carel B. Hoyng, Felice Cardillo Piccolino, Jay K. Chhablani, Timothy Y.Y. Lai, Andrew J. Lotery, Michael Larsen, Frank G. Holz, K. Bailey Freund, Lawrence A. Yannuzzi & Camiel J.F. Boon. (2019) Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Progress in Retinal and Eye Research 73, pages 100770.
Crossref
Maciej Gawęcki, Agnieszka Jaszczuk-Maciejewska, Anna Jurska-Jaśko, Małgorzata Kneba & Andrzej Grzybowski. (2019) Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset. Journal of Clinical Medicine 8:9, pages 1398.
Crossref
Thomas J. van Rijssen, Elon H.C. van Dijk, Paula Scholz, Myrte B. Breukink, Rocio Blanco-Garavito, Eric H. Souied, Jan E.E. Keunen, Robert E. MacLaren, Giuseppe Querques, Sascha Fauser, Susan M. Downes, Carel B. Hoyng & Camiel J.F. Boon. (2019) Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3. American Journal of Ophthalmology 205, pages 1-10.
Crossref
A N Samoylov & A N Korobitsin. (2019) Laser treatment of chronic central serous chorioretinopathy with a point of leakage in the subfoveolar zone without fluorescein angiography. Kazan medical journal 100:4, pages 601-605.
Crossref
Sumit Randhir Singh, Alexandre Matet, Elon H C van Dijk, Alejandra Daruich, Sascha Fauser, Suzanne Yzer, Enrico Peiretti, Sobha Sivaprasad, Andrew J Lotery, Camiel J F Boon, Francine Behar-Cohen, K Bailey Freund & Jay Chhablani. (2019) Discrepancy in current central serous chorioretinopathy classification. British Journal of Ophthalmology 103:6, pages 737-742.
Crossref
Femke M. Haalen, Elon H.C. Dijk, Cornelie D. Andela, Greet Dijkman, Nienke R. Biermasz, Alberto M. Pereira & Camiel J.F. Boon. (2018) Maladaptive personality traits, psychological morbidity and coping strategies in chronic central serous chorioretinopathy. Acta Ophthalmologica 97:4, pages e572-e579.
Crossref
Jingyi Luo, Mingkai Lin, Xinxing Guo, Xueshan Xiao, Jiali Li, Huan Hu, Hui Xiao, Xiaoyu Xu, Yimin Zhong, Shixian Long, Guangwei Luo, Lan Mi, Xiangxi Chen, Lei Fang, Wei Wei, Qingjiong Zhang & Xing Liu. (2019) Novel BEST1 mutations and special clinical characteristics of autosomal recessive bestrophinopathy in Chinese patients . Acta Ophthalmologica 97:3, pages 247-259.
Crossref
Dmitrii S. Maltsev, Alexei N. Kulikov & Jay Chhablani. (2019) Clinical Application of Fluorescein Angiography-Free Navigated Focal Laser Photocoagulation in Central Serous Chorioretinopathy. Ophthalmic Surgery, Lasers and Imaging Retina 50:4.
Crossref
Sarah Mrejen, Chandrakumar Balaratnasingam, Talia R. Kaden, Alexander Bottini, Kunal Dansingani, Kavita V. Bhavsar, Nicolas A. Yannuzzi, Samir Patel, Kevin C. Chen, Suqin Yu, Guillaume Stoffels, Richard F. Spaide, K. Bailey Freund & Lawrence A. Yannuzzi. (2019) Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy. Ophthalmology 126:4, pages 576-588.
Crossref
Catherine Meyerle. (2019) A Backward Glance at Chronic Central Serous Chorioretinopathy. Ophthalmology 126:4, pages 589-590.
Crossref
Maciej Gawęcki. (2019) Micropulse Laser Treatment of Retinal Diseases. Journal of Clinical Medicine 8:2, pages 242.
Crossref
P. L. Volodin, A. V. Doga, E. V. Ivanova, V. A. Pismenskaya, Iu. I. Kukharskaya & E. S. Khrisanfova. (2019) The Personalized Approach to the Chronic Central Serous Chorioretinopathy Treatment Based on the Navigated Micropulse Laser Technology. Ophthalmology in Russia 15:4, pages 394-404.
Crossref
国奇 管. (2019) Role of Optical Coherence Tomography Angiography in Chronic Central Serous Chorioretinopathy with CNV after Intravitreal Injections of Ranibizumab. Hans Journal of Ophthalmology 08:01, pages 33-40.
Crossref
Camiel J.F. Boon, Elon H.C. van Dijk & Suzanne Yzer. 2019. Central Serous Chorioretinopathy. Central Serous Chorioretinopathy 283 292 .
Catherine Meyerle. 2019. Central Serous Chorioretinopathy. Central Serous Chorioretinopathy 21 26 .
Bianca S. Gerendas, Julia-Sophie Kroisamer, Wolf Buehl, Sandra M. Rezar-Dreindl, Katharina M. Eibenberger, Eleonore Pablik, Ursula Schmidt-Erfurth & Stefan Sacu. (2018) Correlation between morphological characteristics in spectral-domain-optical coherence tomography, different functional tests and a patient's subjective handicap in acute central serous chorioretinopathy. Acta Ophthalmologica 96:7, pages e776-e782.
Crossref
Elon H.C. van Dijk, Sascha Fauser, Myrte B. Breukink, Rocio Blanco-Garavito, Joannes M.M. Groenewoud, Jan E.E. Keunen, Petrus J.H. Peters, Greet Dijkman, Eric H. Souied, Robert E. MacLaren, Giuseppe Querques, Susan M. Downes, Carel B. Hoyng & Camiel J.F. Boon. (2018) Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy. Ophthalmology 125:10, pages 1547-1555.
Crossref
H. Lajmi, W. Hmaied, W. Ben Jalel, A. Akremi & L. El Fekih. (2018) Central serous chorioretinopathy: Professional repercussions among agents of the internal security forces. Journal Français d'Ophtalmologie 41:8, pages 739-743.
Crossref
Karima S. Khimani & Rod Foroozan. (2018) Central Serous Chorioretinopathy Associated With Fingolimod Treatment. Journal of Neuro-Ophthalmology 38:3, pages 337-338.
Crossref
Thomas J. van Rijssen, Elon H. C. van Dijk, Greet Dijkman & Camiel J. F. Boon. (2018) Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy. Graefe's Archive for Clinical and Experimental Ophthalmology 256:8, pages 1395-1402.
Crossref
Femke M. van Haalen, Elon H. C. van Dijk, Olaf M. Dekkers, Maurice B. Bizino, Greet Dijkman, Nienke R. Biermasz, Camiel J. F. Boon & Alberto M. Pereira. (2018) Cushing’s Syndrome and Hypothalamic–Pituitary–Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy. Frontiers in Endocrinology 9.
Crossref
D. S. Maltsev, A. N. Kulikov, J. Chhablani, D. S. Kutik & N. V. Arsenov. (2018) Optical coherence tomography in diagnostics and treatment of central serous chorioretinopathy. Vestnik oftal'mologii 134:6, pages 15.
Crossref
Elon H. C. van Dijk, Greet Dijkman & Camiel J. F. Boon. (2017) Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea. Graefe's Archive for Clinical and Experimental Ophthalmology 255:10, pages 2029-2035.
Crossref
Elon H. C. van Dijk, Roula Tsonaka, Ngaisah Klar-Mohamad, Diana Wouters, Aiko P. J. de Vries, Eiko K. de Jong, Cees van Kooten & Camiel J. F. Boon. (2017) Systemic complement activation in central serous chorioretinopathy. PLOS ONE 12:7, pages e0180312.
Crossref
Dimitrios Kourkoutas, George Tsakonas, Aristotelis Karamaounas & Nikolaos Karamaounas. (2017) Chronic Central Serous Chorioretinopathy in a Patient with Pigment Dispersion Syndrome: A Possible Correlation. Case Reports in Ophthalmological Medicine 2017, pages 1-5.
Crossref